NO20014875L - Promedikamenter for trombin inhibitorer - Google Patents
Promedikamenter for trombin inhibitorerInfo
- Publication number
- NO20014875L NO20014875L NO20014875A NO20014875A NO20014875L NO 20014875 L NO20014875 L NO 20014875L NO 20014875 A NO20014875 A NO 20014875A NO 20014875 A NO20014875 A NO 20014875A NO 20014875 L NO20014875 L NO 20014875L
- Authority
- NO
- Norway
- Prior art keywords
- promedients
- thrombin inhibitors
- thrombin
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B43/00—Formation or introduction of functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19915930 | 1999-04-09 | ||
DE19934123 | 1999-07-23 | ||
DE19947920 | 1999-10-06 | ||
PCT/EP2000/003009 WO2000061609A2 (de) | 1999-04-09 | 2000-04-05 | Prodrugs von thrombininhibitoren |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20014875D0 NO20014875D0 (no) | 2001-10-08 |
NO20014875L true NO20014875L (no) | 2001-11-13 |
Family
ID=27219075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20014875A NO20014875L (no) | 1999-04-09 | 2001-10-08 | Promedikamenter for trombin inhibitorer |
Country Status (18)
Country | Link |
---|---|
US (1) | US7144902B1 (xx) |
EP (1) | EP1165601A2 (xx) |
JP (1) | JP2002542165A (xx) |
KR (1) | KR20010108481A (xx) |
CN (1) | CN1355810A (xx) |
AU (1) | AU765244B2 (xx) |
BG (1) | BG105986A (xx) |
BR (1) | BR0009674A (xx) |
CA (1) | CA2370267A1 (xx) |
HK (1) | HK1046289A1 (xx) |
HU (1) | HUP0202401A3 (xx) |
IL (1) | IL145772A0 (xx) |
NO (1) | NO20014875L (xx) |
NZ (1) | NZ515026A (xx) |
PL (1) | PL352824A1 (xx) |
SK (1) | SK14222001A3 (xx) |
TR (1) | TR200102912T2 (xx) |
WO (1) | WO2000061609A2 (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10064797A1 (de) * | 2000-12-22 | 2002-06-27 | Knoll Ag | Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon |
WO2004002985A1 (en) * | 2002-06-27 | 2004-01-08 | Lg Life Sciences Ltd. | Peptidic thrombin inhibitor compound |
EP1625405A1 (en) * | 2003-05-16 | 2006-02-15 | National Institute for Biological Standards and Control (NIBSC) | Activation mixture |
PT1737889E (pt) | 2004-10-19 | 2010-12-13 | Lonza Ag | Método para síntese de péptidos em fase sólida |
US20090215800A1 (en) * | 2005-05-05 | 2009-08-27 | Chroma Therapeutics Ltd | Enzyme and Receptor Modulation |
DK2559690T3 (en) | 2005-05-10 | 2016-04-25 | Incyte Holdings Corp | Modulators of indoleamine 2,3-dioxygenase and methods of use thereof |
EP1971583B1 (en) | 2005-12-20 | 2015-03-25 | Incyte Corporation | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
WO2008036642A2 (en) * | 2006-09-19 | 2008-03-27 | Incyte Corporation | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
CL2007002650A1 (es) * | 2006-09-19 | 2008-02-08 | Incyte Corp | Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras. |
BRPI0915692B8 (pt) | 2008-07-08 | 2021-05-25 | Incyte Corp | compostos derivados de 1,2,5-oxadiazóis, sua forma sólida, sua composição, bem como seus usos |
US9206123B2 (en) | 2009-12-18 | 2015-12-08 | Activesite Pharmaceuticals, Inc. | Prodrugs of inhibitors of plasma kallikrein |
EP2512466A4 (en) | 2009-12-18 | 2013-07-03 | Activesite Pharmaceuticals Inc | PRODRUGS OF INHIBITORS OF PLASMATIC KALLICREIN |
WO2012142308A1 (en) | 2011-04-13 | 2012-10-18 | Activesite Pharmaceuticals, Inc. | Prodrugs of inhibitors of plasma kallikrein |
SG10201803874PA (en) | 2013-11-08 | 2018-07-30 | Incyte Holdings Corp | Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor |
WO2016031815A1 (ja) * | 2014-08-26 | 2016-03-03 | 武田薬品工業株式会社 | 複素環化合物 |
CN106674190B (zh) * | 2016-12-13 | 2019-05-10 | 台州市创源工业技术有限公司 | 一种2-噻吩甲胺的合成方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA951617B (en) | 1994-03-04 | 1997-02-27 | Lilly Co Eli | Antithrombotic agents. |
AR005245A1 (es) * | 1995-12-21 | 1999-04-28 | Astrazeneca Ab | Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion |
TW523513B (en) | 1996-03-01 | 2003-03-11 | Akzo Nobel Nv | Serine protease inhibitors |
DE19632773A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
EP1049673A1 (de) | 1998-01-26 | 2000-11-08 | Basf Aktiengesellschaft | Heterocyclische amidine als kallikrein protease inhibitoren |
CN1289341A (zh) | 1998-01-26 | 2001-03-28 | Basf公司 | 凝血酶抑制剂 |
KR20000047461A (ko) * | 1998-12-29 | 2000-07-25 | 성재갑 | 트롬빈 억제제 |
HUP0203167A3 (en) * | 1999-04-09 | 2003-09-29 | Basf Ag | Peptidic substances, their preparations and their use as complement protease inhibitors |
-
2000
- 2000-04-05 BR BR0009674-1A patent/BR0009674A/pt not_active IP Right Cessation
- 2000-04-05 TR TR2001/02912T patent/TR200102912T2/xx unknown
- 2000-04-05 NZ NZ515026A patent/NZ515026A/en unknown
- 2000-04-05 EP EP00920661A patent/EP1165601A2/de not_active Withdrawn
- 2000-04-05 IL IL14577200A patent/IL145772A0/xx unknown
- 2000-04-05 PL PL00352824A patent/PL352824A1/xx unknown
- 2000-04-05 AU AU41156/00A patent/AU765244B2/en not_active Ceased
- 2000-04-05 US US09/958,349 patent/US7144902B1/en not_active Expired - Fee Related
- 2000-04-05 WO PCT/EP2000/003009 patent/WO2000061609A2/de not_active Application Discontinuation
- 2000-04-05 KR KR1020017012870A patent/KR20010108481A/ko not_active Application Discontinuation
- 2000-04-05 CN CN00807958A patent/CN1355810A/zh active Pending
- 2000-04-05 JP JP2000611551A patent/JP2002542165A/ja active Pending
- 2000-04-05 SK SK1422-2001A patent/SK14222001A3/sk not_active Application Discontinuation
- 2000-04-05 HU HU0202401A patent/HUP0202401A3/hu unknown
- 2000-04-05 CA CA002370267A patent/CA2370267A1/en not_active Abandoned
-
2001
- 2001-10-05 BG BG105986A patent/BG105986A/bg unknown
- 2001-10-08 NO NO20014875A patent/NO20014875L/no not_active Application Discontinuation
-
2002
- 2002-10-30 HK HK02107849.6A patent/HK1046289A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
SK14222001A3 (sk) | 2002-07-02 |
AU765244B2 (en) | 2003-09-11 |
AU4115600A (en) | 2000-11-14 |
HUP0202401A2 (en) | 2002-10-28 |
KR20010108481A (ko) | 2001-12-07 |
CN1355810A (zh) | 2002-06-26 |
BG105986A (bg) | 2002-06-28 |
BR0009674A (pt) | 2002-01-15 |
PL352824A1 (en) | 2003-09-08 |
WO2000061609A3 (de) | 2001-03-15 |
WO2000061609B1 (de) | 2001-04-26 |
NO20014875D0 (no) | 2001-10-08 |
NZ515026A (en) | 2003-10-31 |
EP1165601A2 (de) | 2002-01-02 |
TR200102912T2 (tr) | 2002-03-21 |
HK1046289A1 (zh) | 2003-01-03 |
WO2000061609A2 (de) | 2000-10-19 |
JP2002542165A (ja) | 2002-12-10 |
US7144902B1 (en) | 2006-12-05 |
IL145772A0 (en) | 2002-07-25 |
HUP0202401A3 (en) | 2003-11-28 |
CA2370267A1 (en) | 2000-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE237329T1 (de) | Metalloprotease inhibitoren | |
ATE285821T1 (de) | Fab i inhibitoren | |
NO20012980L (no) | Proteaseinhibitorer | |
PT1224195E (pt) | C-aril-glicosidos inibidores de tgls2 | |
PT1194404E (pt) | Inibidores de aspartil-protease | |
ATE512949T1 (de) | Reninhemmer | |
ATE524441T1 (de) | Vla-4-inhibitoren | |
CY2012007I2 (el) | Πεπτιδομιμητικοι αναστολεις πρωτεασης | |
DE60008527D1 (de) | Zellproliferation inhibitoren | |
DE60035039D1 (de) | Renin inhibitoren | |
DK1272488T3 (da) | Tri-aryl-substitueret ethan-PDE4-inhibitorer | |
NO20014243D0 (no) | Dihetero-substituerte metalloprotease inhibitorer | |
NO20014875L (no) | Promedikamenter for trombin inhibitorer | |
NO20023013L (no) | Substituerte 8-arylkinolin-fosfodiesterase-4-inhibitorer | |
NO20003814D0 (no) | Trombininhibitorer | |
NO20021658L (no) | Asfaltenhemmere | |
ATE252547T1 (de) | Matrixmetalloproteinaseinhibitoren | |
PT1189929E (pt) | Inibidores do factor viia | |
PT1339695E (pt) | Inibidores da farnesiltransferase | |
DE60009260D1 (de) | Thiopyranderivate as mmp-inhibitoren | |
AR028075A1 (es) | Inhibidores de la peptido-desformilasa | |
EP1189618A4 (en) | thrombin | |
DOP2001000307A (es) | Inhibidores de thrombin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |